ABCELLERA BIOLOGICS

abcellera-biologics-logo

AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics.

#SimilarOrganizations #People #Financial #Event #More

ABCELLERA BIOLOGICS

Social Links:

Industry:
Biotechnology Medical Therapeutics

Founded:
2012-01-01

Status:
Active

Contact:
(604) 559-9005

Total Funding:
371.22 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Amazon IPv6 Google Apps For Business Microsoft Azure DNS


Similar Organizations

rakuten-medical-logo

Rakuten Medical

Rakuten Medical is a Bio-technology Company.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.


Current Advisors List

john-hamer_image

John Hamer Board of Director @ AbCellera Biologics
Board_member

Current Employees Featured

kevin-heyries_image

Kevin Heyries
Kevin Heyries Co-Founder, Head of Business Development @ AbCellera Biologics
Co-Founder, Head of Business Development
2017-01-01

carl-hansen_image

Carl Hansen
Carl Hansen CEO @ AbCellera Biologics
CEO

véronique-lecault_image

Véronique Lecault
Véronique Lecault Co-Founder @ AbCellera Biologics
Co-Founder
2012-12-01

jake-beverage_image

Jake Beverage
Jake Beverage Vice President, Alliance Management @ AbCellera Biologics
Vice President, Alliance Management
2021-11-01

véronique-lecault_image

Véronique Lecault
Véronique Lecault Chief Operating Officer @ AbCellera Biologics
Chief Operating Officer
2019-09-01

véronique-lecault_image

Véronique Lecault
Véronique Lecault Corporate Development @ AbCellera Biologics
Corporate Development
2017-01-01

anne-stevens_image

Anne Stevens
Anne Stevens Head of Business Partnering @ AbCellera Biologics
Head of Business Partnering
2020-11-01

bryan-barnhart_image

Bryan Barnhart
Bryan Barnhart Scientific Director @ AbCellera Biologics
Scientific Director
2020-01-01

not_available_image

Neil Berkley
Neil Berkley Chief Business Officer @ AbCellera Biologics
Chief Business Officer
2021-07-01

Founder


carl-hansen_image

Carl Hansen

kevin-heyries_image

Kevin Heyries

véronique-lecault_image

Véronique Lecault

Stock Details


Company's stock symbol is NASDAQ:ABCL

Acquisitions List

Date Company Article Price
2021-09-13 Tetragenetics Tetragenetics acquired by AbCellera Biologics N/A
2020-11-18 Trianni Trianni acquired by AbCellera Biologics 90 M USD
2020-08-20 Dualogics - OrthoMab Dualogics - OrthoMab acquired by AbCellera Biologics N/A
2018-08-01 Lineage Biosciences Lineage Biosciences acquired by AbCellera Biologics N/A

Investors List

eli-lilly_image

Eli Lilly

Eli Lilly investment in Series B - AbCellera Biologics

presight-capital_image

Presight Capital

Presight Capital investment in Series B - AbCellera Biologics

founders-fund_image

Founders Fund

Founders Fund investment in Series B - AbCellera Biologics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series B - AbCellera Biologics

data-collective_image

DCVC

DCVC investment in Series B - AbCellera Biologics

peter-thiel_image

Peter Thiel

Peter Thiel investment in Series B - AbCellera Biologics

viking-global-investors_image

Viking Global Investors

Viking Global Investors investment in Series B - AbCellera Biologics

university-of-minnesota_image

University of Minnesota

University of Minnesota investment in Series B - AbCellera Biologics

government-of-canada_image

Government of Canada

Government of Canada investment in Grant - AbCellera Biologics

founders-fund_image

Founders Fund

Founders Fund investment in Series A - AbCellera Biologics

Investments List

Date Company Article Money raised
2020-09-30 Invetx AbCellera Biologics investment in Series A - Invetx 10.25 M USD
2020-02-24 Invetx AbCellera Biologics investment in Series A - Invetx 15 M USD

Key Employee Changes

Date New article
2021-07-13 AbCellera Appoints Neil Berkley as Chief Business Officer

More informations about "AbCellera Biologics"

AbCellera - Wikipedia

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed a…See details»

Team - AbCellera

Carl is the founding CEO of AbCellera. As an entrepreneurial scientist working at the interface of engineering, biology, and computation, his work is represented in over 90 peer-reviewed …See details»

AbCellera Biologics Inc. - AbCellera Launches Second Phase of …

Sep 21, 2022 AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat …See details»

AbCellera Biologics Inc. - AbCellera Closes $105 Million Series B ...

May 27, 2020 AbCellera is a privately held biotech with a drug discovery platform that searches and analyzes natural immune systems to find antibodies that can be used to prevent and treat …See details»

AbCellera Biologics Inc. - AbCellera Continues …

Jun 22, 2021 AbCellera has also discovered a second antibody, LY-CoV1404, that is being advanced by Eli Lilly & Company to address emerging and future variants. This antibody has been shown to be effective against all currently …See details»

AbCellera - Overview, News & Similar companies | ZoomInfo.com

View AbCellera (www.abcellera.com) location in British Columbia, Canada , revenue, industry and description. ... Explore Complete Organization Structure. ... AbCellera Biologics (ABCL) Q2 …See details»

B.C.'s AbCellera Biologics expands research, production …

May 24, 2023 A Vancouver-based company that helped develop the first antibody therapy treatment for COVID-19 is expanding its research and development capacity as it continues to pursue world-leading new medicines, …See details»

AbCellera - LinkedIn

AbCellera discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders.See details»

Science - AbCellera

Developing potential first-in-class and best-in-class antibody medicines to create innovative, impactful medicines for patients around the world.See details»

Biotech company expands antibody research, production facilities …

May 24, 2023 AbCellera Biologics announced a new $700-million project on Wednesday that will add research and development capacity to a manufacturing plant that has been in the works …See details»

AbCellera Biologics Inc. - AbCellera Partners with the Governments …

May 24, 2023 About AbCellera Biologics Inc. AbCellera is breaking the barriers of conventional antibody drug discovery to bring better medicines to patients, sooner. AbCellera’s engine …See details»

AbCellera - Crunchbase Investor Profile & Investments

AbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes. AbCellera experienced a significant decline in its …See details»

Canada and British Columbia invest in AbCellera’s state-of-the-art ...

May 24, 2023 AbCellera is a Canadian technology company that is breaking the barriers of conventional antibody drug discovery to bring better medicines to patients, sooner.See details»

Partners - AbCellera

Our engine integrates expert teams, technology, and facilities with the data science and automation needed to advance antibody-based medicines from target to clinic with greater …See details»

AbCellera to Build Antibody Manufacturing Facility in Canada

Jun 23, 2021 AbCellera has unveiled plans for the construction of a Good Manufacturing Practices (GMP) manufacturing facility in Vancouver for the production of therapeutic …See details»

AbCellera Biologics Inc. - Investor Relations

Nov 4, 2024 AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, …See details»

Walleye Capital LLC Purchases Shares of 256,881 AbCellera …

3 days ago AbCellera Biologics had a negative net margin of 533.32% and a negative return on equity of 15.73%. During the same period last year, the firm earned ($0.10) earnings per …See details»

AbCellera Biologics Inc. - AbCellera to Collaborate with Biogen to ...

Mar 11, 2024 AbCellera’s engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to clinic in …See details»

AbCellera Biologics (ABCL) Earnings Date and Reports 2025

2 days ago AbCellera Biologics announced Q3 2024 earnings on November 4, 2024, reporting an EPS of -$0.17, which missed analysts' consensus estimates of -$0.14 by $0.03. Quarterly …See details»

AbCellera Biologics Inc. - AbCellera Receives $175.6 million from …

May 3, 2020 AbCellera is a privately held Canadian biotech with a drug discovery platform that searches and analyzes natural immune systems to find antibodies that can be used to prevent …See details»

linkstock.net © 2022. All rights reserved